President Donald Trump unveiled a deal this month with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. Columnists

Why did we build communities that discourage walking? | The Ethical Life podcast

Scott Rada

Science

Obesity remains high in the US, but more states show progress, a new report finds

JONEL ALECCIA Associated Press

Health

As world gets hotter, Americans are turning to more sugar, study finds

SETH BORENSTEIN Associated Press

See Full Page